Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
KO-2806 by Kura Oncology for Colorectal Cancer: Likelihood of Approval
KO-2806 is under clinical development by Kura Oncology and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...
KO-2806 by Kura Oncology for Non-Small Cell Lung Cancer: Likelihood of Approval
KO-2806 is under clinical development by Kura Oncology and currently in Phase I for Non-Small Cell Lung Cancer. According to...
KO-2806 by Kura Oncology for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval
KO-2806 is under clinical development by Kura Oncology and currently in Phase I for Pancreatic Ductal Adenocarcinoma. According to GlobalData,...
KO-2806 by Kura Oncology for Metastatic Renal Cell Carcinoma: Likelihood of Approval
KO-2806 is under clinical development by Kura Oncology and currently in Phase I for Metastatic Renal Cell Carcinoma. According to...
KO-2806 by Kura Oncology for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
KO-2806 is under clinical development by Kura Oncology and currently in Phase I for Head And Neck Squamous Cell Carcinoma...